-
Views
-
Cite
Cite
Lloyd E Butel-Simoes, Doan T M Ngo, Aaron L Sverdlov, Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score, European Heart Journal, Volume 46, Issue 3, 14 January 2025, Pages 285–287, https://doi.org/10.1093/eurheartj/ehae624
- Share Icon Share

Graphical Abstract
Validation of HFA-ICOS tool: current evidence and future directions.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
You do not currently have access to this article.